AIMS: To further characterize the neuropathology of the heterogeneous molecular disorder frontotemporal lobar degeneration (FTLD) with transactive response (TAR) DNA-binding protein of 43 kDa (TDP-43) proteinopathy (FTLD-TDP). METHODS: We quantified the neuronal cytoplasmic inclusions, glial inclusions, neuronal intranuclear inclusions, dystrophic neurites, surviving neurones, abnormally enlarged neurones, and vacuoles in regions of the frontal and temporal lobe using a phosphorylation-independent TDP-43 antibody in 32 cases of FTLD-TDP comprising sporadic and familial cases, with associated pathology such as hippocampal sclerosis (HS) or Alzheimer's disease (AD), and four neuropathological subtypes using TDP-43 immunohistochemistry. Analysis of variance (anova) was used to compare differences between the various groups of cases. RESULTS: These data from FTLD-TDP cases demonstrate quantitative differences in pathological features between: (i) regions of the frontal and temporal lobe; (ii) upper and lower cortex; (iii) sporadic and progranulin (GRN) mutation cases; (iv) cases with and without AD or HS; and (v) between assigned subtypes. CONCLUSIONS: The data confirm that the dentate gyrus is a major site of neuropathology in FTLD-TDP and that most laminae of the cerebral cortex are affected. GRN mutation cases are quantitatively different from sporadic cases, while cases with associated HS and AD have increased densities of dystrophic neurites and abnormally enlarged neurones respectively. There is little correlation between the subjective assessment of subtypes and the more objective quantitative data.
AIMS: To further characterize the neuropathology of the heterogeneous molecular disorder frontotemporal lobar degeneration (FTLD) with transactive response (TAR) DNA-binding protein of 43 kDa (TDP-43) proteinopathy (FTLD-TDP). METHODS: We quantified the neuronal cytoplasmic inclusions, glial inclusions, neuronal intranuclear inclusions, dystrophic neurites, surviving neurones, abnormally enlarged neurones, and vacuoles in regions of the frontal and temporal lobe using a phosphorylation-independent TDP-43 antibody in 32 cases of FTLD-TDP comprising sporadic and familial cases, with associated pathology such as hippocampal sclerosis (HS) or Alzheimer's disease (AD), and four neuropathological subtypes using TDP-43 immunohistochemistry. Analysis of variance (anova) was used to compare differences between the various groups of cases. RESULTS: These data from FTLD-TDP cases demonstrate quantitative differences in pathological features between: (i) regions of the frontal and temporal lobe; (ii) upper and lower cortex; (iii) sporadic and progranulin (GRN) mutation cases; (iv) cases with and without AD or HS; and (v) between assigned subtypes. CONCLUSIONS: The data confirm that the dentate gyrus is a major site of neuropathology in FTLD-TDP and that most laminae of the cerebral cortex are affected. GRN mutation cases are quantitatively different from sporadic cases, while cases with associated HS and AD have increased densities of dystrophic neurites and abnormally enlarged neurones respectively. There is little correlation between the subjective assessment of subtypes and the more objective quantitative data.
Authors: Deepak M Sampathu; Manuela Neumann; Linda K Kwong; Thomas T Chou; Matthew Micsenyi; Adam Truax; Jennifer Bruce; Murray Grossman; John Q Trojanowski; Virginia M-Y Lee Journal: Am J Pathol Date: 2006-10 Impact factor: 4.307
Authors: Kimmo J Hatanpaa; Eileen H Bigio; Nigel J Cairns; Kyle B Womack; Sandra Weintraub; John C Morris; Chan Foong; Guanghua Xiao; Christa Hladik; Tina Y Mantanona; Charles L White Journal: J Neuropathol Exp Neurol Date: 2008-04 Impact factor: 3.685
Authors: Vivianna M Van Deerlin; Elisabeth McCarty Wood; Peachie Moore; Wuxing Yuan; Mark S Forman; Christopher M Clark; Manuela Neumann; Linda K Kwong; John Q Trojanowski; Virginia M-Y Lee; Murray Grossman Journal: Arch Neurol Date: 2007-08
Authors: S Davion; N Johnson; S Weintraub; M-M Mesulam; A Engberg; M Mishra; M Baker; J Adamson; M Hutton; R Rademakers; E H Bigio Journal: Neurology Date: 2007-05-23 Impact factor: 9.910
Authors: Agnes A Luty; John B J Kwok; Elizabeth M Thompson; Peter Blumbergs; William S Brooks; Clement T Loy; Carol Dobson-Stone; Peter K Panegyres; Jane Hecker; Garth A Nicholson; Glenda M Halliday; Peter R Schofield Journal: BMC Neurol Date: 2008-08-29 Impact factor: 2.474
Authors: Johannes Brettschneider; Kelly Del Tredici; David J Irwin; Murray Grossman; John L Robinson; Jon B Toledo; Lubin Fang; Vivianna M Van Deerlin; Albert C Ludolph; Virginia M-Y Lee; Heiko Braak; John Q Trojanowski Journal: Acta Neuropathol Date: 2014-01-10 Impact factor: 17.088
Authors: Daniel T Ohm; Katheryn A Q Cousins; Sharon X Xie; Claire Peterson; Corey T McMillan; Lauren Massimo; Katya Raskovsky; David A Wolk; Vivianna M Van Deerlin; Lauren Elman; Meredith Spindler; Andres Deik; John Q Trojanowski; Edward B Lee; Murray Grossman; David J Irwin Journal: Acta Neuropathol Date: 2022-01-08 Impact factor: 17.088